BriefCase-Quantification vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase-Quantification

by Aidoc Medical

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

These tools are adjacent rather than direct competitors, as BriefCase-Quantification specializes in automated abdominal aortic diameter measurements from CT scans. In contrast, Autoplaque focuses on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. The selection depends on the specific anatomical region and pathology requiring AI-powered quantitative analysis.

Choose BriefCase-Quantification if…

Choose BriefCase-Quantification if your radiology department requires an automated, cloud-based solution for precise abdominal aortic diameter measurements from CT scans. This tool is ideal for streamlining workflows and integrating quantitative aortic assessments into a broader enterprise AI platform to support clinical decision-making for various aortic conditions.

View BriefCase-Quantification →

Choose Autoplaque if…

Choose Autoplaque if your cardiology or radiology practice needs a dedicated, workstation-based software for in-depth quantitative analysis of coronary plaques and luminal stenoses from CT angiography. This tool is specifically designed to aid in comprehensive heart attack risk prediction and guide treatment strategies based on detailed coronary artery assessment.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase-Quantification	Autoplaque
Pricing	Contact for pricing	Unknown
Deployment	Cloud-based	Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase-Quantification

Tool A, BriefCase-Quantification, is cloud-based and integrates with existing image review software, indicating a more streamlined and accessible user experience. Tool B, Autoplaque, is workstation-based, which typically requires local installation and may present more hurdles for widespread deployment and ease of access.

Clinical Value

Tie

Both tools are FDA-cleared and provide critical quantitative analysis for cardiovascular conditions, aiding in clinical decision-making. BriefCase-Quantification focuses on abdominal aortic diameter measurements, while Autoplaque analyzes coronary plaques and stenoses for heart attack risk. Both address significant clinical needs within their respective domains.

Pricing & Value

BriefCase-Quantification

Tool A, BriefCase-Quantification, offers more transparency regarding its pricing model, stating it's contract-based with annual or multi-year options and financing available. Tool B, Autoplaque, has not disclosed any pricing information, making it impossible to assess its value proposition.

Enterprise Readiness

BriefCase-Quantification

Tool A, BriefCase-Quantification, is part of Aidoc's aiOSu2122 enterprise AI platform, is cloud-based, and explicitly states HIPAA compliance and BAA availability. Tool B, Autoplaque, is workstation-based and does not specify BAA or HIPAA compliance, making it less suitable for large-scale enterprise deployment.

Innovation

Autoplaque

While both utilize AI for quantitative analysis, Autoplaque's focus on detailed coronary plaque characterization and luminal stenoses for heart attack risk prediction, including automated segmentation that is reviewable and editable by clinicians, represents a slightly more advanced and nuanced application of AI in diagnostics. BriefCase-Quantification's automated diameter measurement, while valuable, is a more established application.

Support & Docs

BriefCase-Quantification

Aidoc (Tool A) clearly outlines a comprehensive customer success program, offering training, educational content, and dedicated support channels. For Autoplaque (Tool B), direct customer support and comprehensive documentation as a standalone product from Cedars-Sinai AIM are not as clearly articulated or easily discoverable through public information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase-Quantification	Autoplaque
Tool Name	BriefCase-Quantification	Autoplaque
Company	Aidoc Medical	Cedars-Sinai Medical Center: AIM
Primary Clinical Focus	Automated abdominal aortic diameter measurements from CT scans	Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images
Key Measurement/Analysis	Automated abdominal aortic diameter measurement	AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses
Platform Integration/Type	Part of Aidoc's aiOSu2122 enterprise AI platform	Workstation-based post-processing application

Videos

Demos, reviews, and walkthroughs featuring BriefCase-Quantification and Autoplaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific anatomical areas and clinical conditions do these AI tools address?

BriefCase-Quantification (Tool A) is designed for automated abdominal aortic diameter measurements from CT scans, assisting in clinical decision-making and streamlining workflows. [cite: Tool A] It is indicated for analyzing CT exams with contrast that include the abdominal aorta in adults or transitional adolescents aged 18 and older, to evaluate normal and aneurysmal abdominal aortas. Autoplaque (Tool B) focuses on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. [cite: Tool B] It helps physicians with measurements of coronary artery stenosis and provides measurements for coronary plaque and coronary artery remodeling.

How do the core functionalities of these tools differ?

BriefCase-Quantification (Tool A) primarily offers automated abdominal aortic diameter measurement and radiological image management and processing. [cite: Tool A, 6] It integrates with image review software and is part of Aidoc's aiOSu2122 enterprise AI platform. [cite: Tool A] Autoplaque (Tool B) provides AI-powered quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses in coronary arteries from CT angiographic images. [cite: Tool B] It also features automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician. [cite: Tool B, 1]

Can clinicians review and edit the AI's automated segmentations or measurements?

BriefCase-Quantification (Tool A) assists medical specialists with quantitative measurements, and its output is transferred to an image review software for user review. [cite: Tool A, 6] The diameter marking is for visualization and measurement, and the results are not intended to be used on a stand-alone basis for clinical decision-making and must be reviewed by a radiologist. Autoplaque (Tool B) explicitly states that its automated vessel, plaque, and lumen segmentation is reviewable and editable by the clinician. [cite: Tool B, 1]